TX-AUREA-SOFTWARE-INC
11.1.2022 17:02:08 CET | Business Wire | Press release
Aurea Software Inc. , the “Netflix of business software,” announced Deutsche Telekom is piloting its first-ever Virtual Office using Sococo software from Aurea . Used to better connect its distributed workforce and increase culture and collaboration across the company’s customer service teams, the pilot will run until March.
Deutsche Telekom customer service teams — comprised of 30,000 employees across Germany — are distributed throughout the country. Despite using a geographically distributed and hybrid work setting, team members need to be able to “work as one” to deliver optimal customer experiences.
Using Aurea’s Sococo solution, Deutsche Telekom is at the forefront of solving this problem of connection and culture in the geographically distributed and hybrid workplace by launching a Virtual Office that allows workers to enjoy the same level of connection and presence online that they once enjoyed in person.
“Hybrid work is here to stay. The pandemic started it, but workers embraced it, and there is no going back to a 100 percent in-person work world. And while research supports that working from home has many benefits, it also creates unique challenges,” said Scott Brighton, CEO of Aurea. “Workers can’t connect in the hallways the way they once did. They don’t meet new people on campus or when visiting other offices around the world. Common virtual meeting communication tools have made their work world smaller — encouraging them to stay in regular communication with people they already know, but not empowering them to discover new people or new ideas. This has led to a lack of experiencing a vibrant culture of diversity that was more prominent when workers came into a physical office.”
Brighton added, “With the creation of its Virtual Office, Deutsche Telekom is leading the industry by creating a hybrid-work environment that offers employees more ways to connect, collaborate, and build culture no matter where they are in the world.”
Deutsche Telekom’s Virtual Office looks and feels like an actual office — however, it’s online instead of in a physical building. There are gathering spaces, meeting and conference rooms, and even break areas, giving every employee the ability to see where colleagues are and what they are doing. This creates a rich sense of presence that is missing from basic communication tools that only show a generic status color next to a list of colleagues. Employees can meet and connect with new people using virtual meeting experiences specifically designed to create the casual connections present in in-office settings. For example, Deutsche Telekom’s Virtual Office has a Coffee Roulette room where employees are randomly connected to another co-worker they may not already know. They can spend a few minutes getting to know each other — sharing details about their roles, how they can help each other, and even what inspires them.
Aurea’s Sococo solution is centered around going beyond the basic communication aspects that traditional virtual meeting platforms provide to build true culture and connection.
“Like many large enterprises, Deutsche Telekom thrives, in part, due to the diverse backgrounds and skills of our workforce coming together to share knowledge and collaborate to solve customer issues more efficiently,” said Gereon Hammel, vice president of business development at Deutsche Telekom. “Many of the methods we’ve traditionally relied on to forge this collaboration are lost when functions are shrunk to closed and niche calls with immediate team members. By partnering with Aurea to launch this Virtual Office, we can enable important components of an in-person work environment within our hybrid work setting. This allows us to leverage our scale and diverse workforce, without requiring everyone to be in the same physical office space. The ease at which we can implement the Sococo solution across our team means our Virtual Office can be implemented in a matter of minutes.”
REGISTER TODAY : Hear more from Gereon Hammel and Scott Brighton on how to enable digital connection and build a Virtual Office during VentureBeat’s Future of Work Summit . Sign up today for the January 12 event.
About Aurea:
Aurea helps global businesses accelerate digital transformation through unlimited access to the world’s first business software library, which includes solutions that enable the Future of Commerce, work, and IT. Our customers enjoy access to every product in our portfolio, all of which are cloud-based, enterprise-scale, and easy-to-use with one simple subscription. Our unique operating model and acquisition strategy grows our software portfolio every year, creating unparalleled value and unlimited possibility. For more information, visit Aurea.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220111005342/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
